Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

Longer period between Pfizer doses is not problematic - CSS

Longer period between Pfizer doses is not problematic - CSS

Official from pharmaceutical company had said stick to 21 days

ROME, 12 May 2021, 11:26

Redazione ANSA

ANSACheck

- ALL RIGHTS RESERVED

-     ALL RIGHTS RESERVED
- ALL RIGHTS RESERVED

A senior Italian health official said Wednesday that increasing the time between the first and second doses of the Pfizer COVID-19 vaccine from three weeks to up to six is not problematic after an official from the pharmaceutical company suggested it was best to stick to span of 21 days.
    "I say this very clearly as a doctor," Franco Locatelli, the president of Italy's Higher Health Council (CSS) and the coordinator of the CTS expert panel advising the government on its response to the coronavirus, told RAI television.
    "Extending the period between administration of the first and the second doses to the sixth week, so 42 days, does not impair the effectiveness of the immunization in the slightest and it enables us to give out more doses of the vaccine".
    On Tuesday Pfizer Italia Medical Director Valeria Marino said that her company's COVID vaccine was designed to be given in two doses three weeks apart.
    But on Wednesday the company stressed that "recommendations on alternative dosage regimes are the competence of the health authorities".
    Locatelli said he understood Pfizer 's "protective attitude" regarding studies done on the three-week period between doses.
    But he added that "studies in real life have shown its effectiveness after a period of 42 days too.
    "So statements like yesterday's only create concern and it would be desirable to avoid them".
   

ALL RIGHTS RESERVED © Copyright ANSA

Not to be missed

Share

Or use

ANSA Corporate

If it is news,
it is an ANSA.

We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.